Eagle Pharmaceuticals Completes Acquisition of Acacia Pharma Group plc, Expanding Acute Care Footprint
Adds two U.S. Food and Drug Administration approved new chemical entities with strong patent protectionBARHEMSYS® and BYFAVO® join Eagle portfolio, with an estimated combined $3.1 billion... | June 9, 2022